Akebia Therapeutics (AKBA)
(Delayed Data from NSDQ)
$1.37 USD
+0.03 (1.86%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $1.36 -0.01 (-0.73%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/13/24 |
---|---|
Current Quarter | -0.09 |
EPS Last Quarter | 0.00 |
Last EPS Surprise | 100.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.28 |
Next Year | -0.19 |
EPS (TTM) | -0.28 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 41.52M | 47.27M | 189.59M | 157.94M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 42.93M | 48.75M | 191.06M | 189.98M |
Low Estimate | 40.10M | 45.79M | 188.11M | 125.90M |
Year ago Sales | 40.13M | 56.38M | 194.75M | 189.59M |
Year over Year Growth Est. | 3.45% | -16.16% | -2.65% | -16.69% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.09 | -0.07 | -0.28 | -0.19 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.10 | -0.08 | -0.34 | -0.54 |
High Estimate | -0.07 | -0.06 | -0.21 | 0.17 |
Low Estimate | -0.10 | -0.08 | -0.34 | -0.54 |
Year ago EPS | -0.14 | -0.06 | -0.28 | -0.28 |
Year over Year Growth Est. | 35.71% | -16.67% | 0.00% | 32.14% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.09 | -0.07 | -0.28 | -0.19 |
7 Days Ago | -0.09 | -0.07 | -0.28 | -0.19 |
30 Days Ago | -0.09 | -0.07 | -0.27 | -0.19 |
60 Days Ago | -0.09 | -0.07 | -0.29 | -0.15 |
90 Days Ago | -0.09 | -0.08 | -0.29 | -0.13 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.09 | -0.07 | -0.34 | -0.19 |
Zacks Consensus Estimate | -0.09 | -0.07 | -0.28 | -0.19 |
Earnings ESP | 0.00% | 0.00% | -23.64% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.00 | -0.08 | -0.06 | -0.14 | NA |
Estimate | -0.05 | -0.09 | -0.03 | -0.15 | NA |
Difference | 0.05 | 0.01 | -0.03 | 0.01 | 0.01 |
Surprise | 100.00% | 11.11% | -100.00% | 6.67% | 4.45% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more